Jean‐Philippe Vuillez

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

Jean‐François Chatal, L. Campion, Françoise Kraeber‐Bodéré et al. · Journal of Clinical Oncology · 2006 · 228 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.

Françoise Kraeber‐Bodéré, Caroline Rousseau, Caroline Bodet‐Milin et al. · PubMed · 2006 · 127 citations

Medicine, Nuclear Medicine, Oncology +17

Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy

A. Oudoux, Pierre‐Yves Salaün, Claire Bournaud et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 92 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

Pierre‐Yves Salaün, L. Campion, Claire Bournaud et al. · Journal of Nuclear Medicine · 2012 · 80 citations · Full text

Medicine, Oncology, Pharmacology +17

In vivo imaging of tumour angiogenesis in mice with the αvβ3 integrin-targeted tracer 99mTc-RAFT-RGD

Lucie Sancey, Valérie Ardisson, Laurent Riou et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 64 citations

Medicine, Oncology, Radiology +16